Related Experiment Video
Updated: Aug 26, 2025

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
[New insights into the bone marrow niche in multiple myeloma revealed by single-cell profiling technologies]
1Department of Hematology and Oncology, Osaka University Graduate School of Medicine.
Several types of nonhematopoietic cells, including mesenchymal stem or progenitor cells, mature mesenchymal cells, and endothelial cells, and mature hematopoietic cells such as monocytes, macrophages, NK cells, T cells, and B cells regulate the proliferation and survival of myeloma cells. The cell functions adjacent to myeloma cells is specialized by the location of these cells, called a niche. This review focuses on the role and interaction of cellular components of the myeloma-specific niche revealed by studies that utilized the recently developed experimental techniques of single-cell RNA sequencing and high-parameter cytometry. In the myeloma niche, immune cells and mesenchymal cells regulate tumor proliferation. Bone marrow inflammation induced by multiple myeloma, tumor cells, mesenchymal stromal cells, and immune cells interact, results in the dysregulation of anti-tumor immunity. This complex network could affect tumorigenesis, disease progression, and treatment resistance of multiple myeloma.
Several types of nonhematopoietic cells, including mesenchymal stem or progenitor cells, mature mesenchymal cells, and endothelial cells, and mature hematopoietic cells such as monocytes, macrophages, NK cells, T cells, and B cells regulate the proliferation and survival of myeloma cells. The cell functions adjacent to myeloma cells is specialized by the location of these cells, called a niche. This review focuses on the role and interaction of cellular components of the myeloma-specific niche revealed by studies that utilized the recently developed experimental techniques of single-cell RNA sequencing and high-parameter cytometry. In the myeloma niche, immune cells and mesenchymal cells regulate tumor proliferation. Bone marrow inflammation induced by multiple myeloma, tumor cells, mesenchymal stromal cells, and immune cells interact, results in the dysregulation of anti-tumor immunity. This complex network could affect tumorigenesis, disease progression, and treatment resistance of multiple myeloma.

